Tuesday, July 21, 2020 7:46:14 PM
The Float Is Razor Thin
Chart Is Trending Bullish
Substantial Market Opportunity
Strong And Growing Patent Portfolio
Plans To Uplist
Expected FDA 510(k) Submission For 2nd Product
Majority of NeuroOne’s products expect US FDA 501 process.
Comapny Profile
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, essential tremors and other related neurological disorders that may improve patient outcomes and reduce procedural costs.
Why NeuroOne?
NeuroOne (OTCQB:NMTC) is a next generation electrode technology company specializing in development and commercialization of hi-definition thin film electrodes for the diagnosis and
treatment of various neurological conditions such as epilepsy, Parkinson’s Disease
and chronic pain due to failed back surgery syndrome
First FDA 510(k) clearance for cortical electrode product family December 2019
Potential ability to perform recording, ablation and stimulation with the same electrode
Minimally invasive flexible patented technology leverages printed circuit technology
We expect our technology could reduce manufacturing costs, procedural costs and improve patient outcomes
Mayo Clinic assisted in the development process, successfully used devices in humans as part of a research protocol and currently maintains an ownership position in the Company. WARF (University of Madison-Wisconsin’s Alumni Research Foundation) also assisted in development)
Well positioned electrode technology has strong potential for future use in DBS (deep brain stimulation) spinal cord stimulation and artificial intelligence applications, which may play an important future role in treating patients with more complex neurological issues
Experienced Management Team, Board of Directors and two Advisory Boards with highly acclaimed physicians from prestigious institutions
Strong and growing patent portfolio(MI tool, drug delivery, spinal cord stim )
The Bottom Line
With its low-float and recent announcements, we believe that NMTC is in for a huge day of trading.
The Company is in the midst of a major growth period, and we believe it has the potential to double in price from here.
Having been granted the regulatory green light to begin bringing its product line to market, Neuro-One’s stock is still ranging within its lows (currently at around $2.00 per share). This shouldn’t come as a surprise, as the emerging healthcare space is often too specialized a sub-industry for most mainstream investors to monitor let alone understand.
But for the few who can grasp both the relevance and growth potential of Neuro-One’s product line, the company offers early investors an opportunity to get in on a much-needed medical product that, to date, sees neither comparable solutions nor formidable competition.
Traders looking for a company that is committed to growth, and with plenty of upside should add NMTC to the top of their watchlist immediately..By Viewing this Content, you Agree that you Have Read and are in Full Understanding of both our Disclaimer & Privacy Policy(*Remember to use a Stop-Loss Order to protect your gains, as well as limit possible losses.)
Best Regards
Official InvestorsHub (IHUB) Profile for #TFMG | #theFinancialMarketingGroup:
#BullishCharts - https://investorshub.advfn.com/BullishChartscom-38003/
#TopMarketGainers - https://investorshub.advfn.com/Chart-Analysis-TopMarketGainerscom-36847/
Recent NMTC News
- NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14 • GlobeNewswire Inc. • 05/10/2024 06:43:56 PM
- NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology • GlobeNewswire Inc. • 04/10/2024 01:00:00 PM
- NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes • GlobeNewswire Inc. • 04/09/2024 01:05:00 PM
- NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co. • GlobeNewswire Inc. • 04/04/2024 01:00:00 PM
- NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System • GlobeNewswire Inc. • 03/26/2024 01:00:00 PM
- NeuroOne® to Participate in the 36th Annual Roth Conference • GlobeNewswire Inc. • 03/08/2024 05:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 07:10:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 07:01:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 06:50:35 PM
- NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/23/2024 10:10:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 04:08:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 03:57:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 03:44:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 03:14:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:15:12 PM
- NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 02/13/2024 09:00:00 PM
- NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13 • GlobeNewswire Inc. • 02/08/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 06:51:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 06:41:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 06:29:21 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/31/2024 09:09:29 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 01/29/2024 02:02:32 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/29/2024 02:00:30 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/05/2024 09:16:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 06:30:06 PM
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM